For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.
Buffett says US shouldn’t use “trade as a weapon” as Trump has done with tariffs
While Buffett said it is best for trade to be balanced between countries, he doesn’t think Trump is going about it the right way with
May 3, 2025